Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
Abstract
To compare Prostate Health Index (PHI) and prostate‐specific antigen (PSA) density as secondary tests after multiparametric magnetic resonance imaging (mpMRI) in improving the detection accuracy of Gleason grade group (GG) 2‐5 prostate cancer (PCa) and in decreasing unnecessary biopsies in a multiethnic biopsy‐naïve population.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 15, 2021
- Source ID
- 10.1002/bco2.91
Entities
People
- Adam B Murphy
- Andre Kajdacsy‐balla
- Courtney M.P. Hollowell
- Daniel P. Dalton
- David D. Casalino
- Edward M. Schaeffer
- James Stinson
- Josephine Abelleira
- Karen Ferrer
- Maria Ruden
- Marin Sekosan
- Patrice King‐lee
- Peter H Gann
- Rick A. Kittles
- Rilwan Babajide
- Samuel Carbunaru
- Ximing Yang
Organizations
- Northwestern University
- United States Department of Defense
- University of Chicago
- University of Illinois at Chicago
- V Foundation for Cancer Research